EU patients may miss out on medicines in no-deal Brexit, says AstraZeneca

Pharmaceutical giant says it will have to test crucial drugs in UK and EU to ensure they can cross borders

Pharmaceutical giant AstraZeneca has warned that patients in the European Union may not be able to receive vital medicines from the UK if the company does not successfully prepare for a no-deal Brexit.

The manufacturer of cancer, heart and lung drugs told an official Dutch government website that it was going to have to test medicines in both the UK and the EU to ensure they could cross the border in all Brexit scenarios.

Continue reading...

from The Guardian https://ift.tt/2AXluJQ
via
0 Comments